Electromed (ELMD) vs Profound Medical (PROF)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Electromed (ELMD) has outperformed Profound Medical (PROF) over the past year, gaining 10.7% versus a gain of 2.5%. Over five years, ELMD leads with a +153.0% price change compared with -54.0% for PROF. Profound Medical is the larger company by market cap ($252.5 million vs $230.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELMD | PROF |
|---|---|---|
| Share price | $27.80 | $6.91 |
| Market cap | $230.38M | $252.49M |
| 1-day change | -1.42% | +21.65% |
| YTD return | -4.53% | -12.20% |
| 1-year return | +10.67% | +2.52% |
| 5-year return | +152.96% | -53.96% |
| P/E ratio (TTM) | 21.72 | — |
| Forward P/E | 45.57 | — |
| EPS (TTM) | $1.28 | $-1.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $47.40 | $8.95 |
| 52-week low | $23.01 | $4.80 |
| Distance from 52-week high | -41.35% | -22.79% |
| Analyst consensus | none | none |
| Avg. price target upside | +74.46% | +61.22% |
| Average volume | 104.86K | 125.35K |
| Shares outstanding | 8.29M | 36.54M |
| Employees | 195 | 162 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Electromed
ELMD stock →Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 195 employees
About Profound Medical
PROF stock →Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue.
Health Care · Medical/Dental Instruments · 162 employees
ELMD vs PROF FAQ
Which is bigger, Electromed or Profound Medical?
Profound Medical (PROF) is larger, with a market capitalization of $252.49M compared with $230.38M for Electromed (ELMD).
Which stock has performed better over the past year, ELMD or PROF?
ELMD returned +10.67% over the past 12 months, compared with +2.52% for PROF (price return, excluding dividends). Past performance does not predict future results.
Are Electromed and Profound Medical in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Electromed and Medical/Dental Instruments for Profound Medical.